Navigation Links
Data on Telavancin and Micafungin Hold Promise of New Therapeutic,Options in Fight Against Serious Infectious Disease

- Studies Reinforce Astellas Commitment to Overcoming Critical Shortage of New Antimicrobial Agents

MUNICH, Germany, April 02, 2007 /PRNewswire/ --Study results presented at the 17th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) show that the antibiotic telavancin, and the antifungal micafungin, both have the potential to meet a significant unmet need in the fight against serious hospital-acquired infections (HAIs).

Hospital-acquired, or nosocomial infections, are one of the leading causes of death and increased morbidity amongst patients in a hospital setting.(1) Estimates suggest that HAIs cost the UK economy GBP1 billion a year.(2) The greatest contributor to this cost is the increased length of hospital stay for patients with infection.(3),(4),(5)

Telavancin data

Data presented from ATLAS 1 and ATLAS 2, two multinational phase 3 studies, show that telavancin was found to be effective for the treatment of patients with complicated skin and skin structure infections (cSSSIs), including those caused by Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA).(6),(7)

The results of the two double blind parallel studies, in which 1,867 patients were treated, showed that telavancin compared favorably to standard therapy in clinical cure, microbiological eradication, and overall therapeutic response rates. The safety profile of telavancin in these studies was compatible with treatment of patients with serious infections due to resistant bacteria.

    Astellas Pharma Ltd


    Lovett House, Lovett Road,

    Staines, TW18 3AZ

    Tel: +44(0)1784-419615

    Fax: +44(0)1784-419401

    Astellas Pharma Ltd.

    Registered in England &

    Wales 0787610

Commenting on the study results, investigator Professor M Stryjewski, Duke Clinical Research Institute, Durham, North Carolina, USA said, "Antibio
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
2. New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
5. Anti-TNF Golimumab Continues to Show Promise in Phase II Rheumatoid Arthritis Study
6. Trial Results with Intranasal Fentanyl Hold Promise for Treatment of Breakthrough Pain in Cancer
7. Merck at ASCO 2007: Spectrum of Studies Reinforces Promise of Erbitux for Colorectal and Head and Neck Cancer Patients
8. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
9. RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds Significant Promise for Treating Breast Cancer
10. Alzheimers Drug Shows Promise in Fighting Cancer
11. Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer

Post Your Comments:
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Pain Management - Global Trends ,...nagement---Global-Trends.html ,, Widespread av...agement clinics, and the advent of new drugs have ...ent market. Healthcare reforms and reimbursement s...
(Date:11/25/2009)...ands and JOHANNESBURG, November 25 ...is Discovery announced today,that they have signed...companies, services. , Pyxis,s world clas...tise,will be coupled with iThemba,s service divisi...pport to projects identified through Pyxis,intern...
(Date:11/25/2009).... 25 ChemoCentryx, Inc., announc...Company,s PROTECT-1 (the Prospective Randomized Or... Traficet-EN(TM) (CCX282-B) in patients with moder...l efficacy with a favorable safety and tolerabilit...nical efficacy in the reduction of disease severit...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Ten Years Later 3A O I S Media Leads Physician Job Board Industry with Innovative Technology 53688 1Ten Years Later 3A O I S Media Leads Physician Job Board Industry with Innovative Technology 53688 2Report 3A Microsoft Sponsoring Ads for Rogue Internet Pharmacies 53685 1Report 3A Microsoft Sponsoring Ads for Rogue Internet Pharmacies 53685 2Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 1Ten Professional Societies Join Forces to Develop Obesity Medicine Certification Examination 53683 2
...pondents against expanding statin use broadly in w...N.J., Nov. 25 JUPITER, a clinical trial suggestin...f healthy patients with elevated CRP, should not p...ing to a national poll directed at health professi...line poll conducted by medical news site MedPage T...
...n Clinical Trial to Assess Survival of Patients Re... Unresectable Hepatocellular Carcinoma , , BE...nc. (LSO) today announced the completion of enroll...nfusion Therapy(TM) (Litx(TM)) as a treatment for ...known as hepatoma or primary liver cancer. , , ...
Other Medicine Technology:Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4
(Date:11/27/2009)..., Nov. 27 /PRNewswire/ - Uploadable USB pedometers... in wellness. A combination of advanced accelerome...lving a long term concern over the accuracy of sel...auge and reward improved participation in a fitnes... the first wellness suppliers to integrate this te...
(Date:11/27/2009)...SUR-SEINE, France, Nov. 27 Team Ga...ycling team dedicated to ethical sporting and deve...nnounced today that it will become Team Garmin-Tra...as a new sponsor of the team. Transitions Optical ...ewear, offering the most advanced photochromic tec...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allrecipes...-high Thanksgiving traffic numbers, with more than... providing a clear picture of what was served on t...hanksgiving meal in 2009 weighed in at 2,225 calor...ar,s feast. According to the Allrecipes site, Swe...
(Date:11/26/2009)...Nov. 27 With cold and flu season u...od practices to control the spread of infections a...ot only to keep ourselves healthy, but to avoid tr...erty, RN, MS, CIC (certified in infection-control)...ational health at Hospital for Special Surgery (HS...
(Date:11/26/2009)...ll when on an emotional rollercoaster, study finds...-- Call it the fear factor meets the jubilant spor...-- especially those who root for the winning team ...ly contested match and victory was in doubt, produ... on that this Thanksgiving weekend as you,re glued...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3
...nence can be reduced through losing weight by diet...en with prediabetes, which is a condition where bl...ve not yet become diabetic. These are the r... clinical study funded by the National Institutes ...
...ue in children that can often be disabling and one...nce from school could mainly be due to their genet...niversity's School of Medicine (Department of Psyc...etic and environmental causes. They explaine...
...that Asians including Indians are being hit the mo...e one-size-fits-all diagnosis done by doctors that...-mass index (BMI) - a measure of weight divided by...l health at a lower cut-off point than in Caucasia...
...ve reported a breakthrough, towards the testing an... The researchers from the US National Instit... had high levels of two proteins several months be...ly all cases of pre-eclampsia, which is a severe c...
...e third leading cause of death in Canada ahead of ... prevalent problem within Aboriginal communities. ... September 10, 2006, two experts from the Canadian...s. “One important factor that predisposes in...
...dren's agency, UNICEF and the Barcelona soccer clu...s agreed to donate $1.9 million a year over the ne...en with AIDS in developing countries. Their ...infected with HIV, the virus that causes AIDS. ...
Other Medicine News:Health News:Bladder Control following Weight loss in women with Prediabetes 2Health News:Bladder Control following Weight loss in women with Prediabetes 3Health News:Placental Proteins Could Be Responsible For Pre-eclampsia 2Health News:Getting Serious About Suicide Prevention 2
ImmunoDOT TORCH Test
...tive enzyme immunoassays (EIA) for the presumptive... or IgM, respectively) in serum. Equivocal or posi...ed with a standardized western blot procedure. The...linical diagnosis of B. burgdorferi infection (Lym...
...is an enzyme immunoassay (EIA) test for screening ...oglobulin and human thyroid peroxidase (microsome)...as an aid in the diagnosis of thyroid disorders. A...d by detection of anti-thyroid antibodies, primari...
...ning microwell EIA and western blot advantages. Li...ly meaningful cutoff is applied to nitrocellulose ...agent system used in most western blot assays., ...tecting the four common extractable nuclear antige...
Medicine Products: